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Background: Ovarian hyperstimulation caused by follicle-stimulating hormone-secreting gonadotroph cell
adenoma is a rare, with a few reported cases, but almost certainly unnoticed cases occur because of the absence of
detailed examinations. We retrospectively reviewed 200 patients treated for gonadotroph cell adenoma in our
institute and identified 26 women of reproductive age. Two of these 26 patients had a history of ovarian cysts. One
patient was considered to have had typical ovarian hyperstimulation, successfully treated by transsphenoidal
surgery. The other patient initially underwent transsphenoidal surgery because of visual disturbance, but
endocrinological examinations suggested possible relationships with previous ovarian hyperstimulation. We present
the former case and discuss the latent risk of failure to identify this entity.
Case presentation: A 36-year-old woman with a sellar tumor was referred to our hospital with suspected ovarian
hyperstimulation. She had a history of repeated surgery for ovarian cysts. Serum follicle-stimulating hormone and
estradiol levels were within the normal ranges, and only the luteinizing hormone level was suppressed significantly.
Transsphenoidal surgery achieved gross total tumor removal, and the histological diagnosis was follicle-stimulating
hormone-secreting gonadotroph cell adenoma. The serum follicle-stimulating hormone, luteinizing hormone, and
estradiol levels returned to the normal ranges postoperatively, and the ovarian cysts subsequently decreased in size
without particular interventions.
Conclusion: Ovarian hyperstimulation could regress after resolving the causes of high follicle-stimulating hormone
level, so avoiding unnecessary ovary surgery. Detailed endocrinological examination including estradiol evaluation
with pituitary imaging is quite important in women of reproductive age to establish the correct diagnosis.
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Pituitary adenomas have been identified with increasing
frequency in the last decade. Gonadotroph cell adenomas
are the most common histological subtype, accounting for
approximately 80% of non-functioning pituitary adenomas
and 40% of all clinically recognized macroadenomas [1,2].
Immunohistochemical examination reveals gonadotropin
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distribution, and reproduction in any mediumhormone (FSH), luteinizing hormone (LH), and/or a-
subunit. However, secretion is usually low, so that these
hormones frequently fail to manifest as clinical signs and
symptoms [2]. Neurological symptoms occur only after the
tumor has compressed the optic chiasm, resulting in visual
disturbance. Therefore, gonadotroph cell adenomas are
often diagnosed as non-functioning pituitary adenomas.
Ovarian cyst is a common disorder in young women
with various etiologies. Ovarian hyperstimulation induced
by inappropriate FSH oversecretion from adenoma cells
may manifest as multiple ovarian cysts, although FSH-
secreting gonadotroph cell adenoma is rare as the cause oftral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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secreting gonadotroph cell adenomas have presented with
symptoms of gonadotropin oversecretion [4-7]. The endo-
crinological profiles of these reported cases generally
showed normal to slightly high FSH concentration and
extremely low LH concentration, which are indicators
for diagnosis [3]. However, the incidence of ovarian
hyperstimulation caused by pituitary adenoma is un-
known because of the absence of detailed gynecological
examination.
We report a case of FSH-secreting pituitary adenoma
associated with recurrent ovarian cysts, and describe the
characteristics of gonadotroph cell adenoma in women
of reproductive age to identify the incidence and clinical
characteristics of this pathology.
Case presentation
A 36-year-old woman with a sellar tumor was referred
to our hospital. She had a history of repeated ovarian
cysts. She presented with abdominal pain and metror-
rhagia at age 32 years, and transvaginal ultrasonography
revealed bilateral enlarged ovaries with multiple cysts
(expanded follicles) (Figure 1A). No ascites was detected.
The diagnosis was ovarian cyst and enucleation surgery
was performed (Figure 1B). Her endocrinological profile
after ovary surgery was FSH 12.0 mIU/ml (normal range
for follicular phase, 3.01-14.72 mIU/ml) and estradiol
1820 pg/ml (normal range for follicular phase, 20–
350 pg/ml). However, she still suffered metrorrhagia, so
administration of oral contraceptives was started. Three
years later, the ovarian cysts recurred, and her endo-
crinological profile was FSH 10.92 mIU/ml, LH <0.10
mIU/ml (normal range for follicular phase, 1.76-10.24
mIU/ml), estradiol 304 pg/ml, and prolactin 56.68 ng/ml
(normal range, 4.91-29.32 ng/ml), which indicated that
the serum FSH and estradiol levels were within the
normal ranges, and serum LH level was significantly
suppressed. Magnetic resonance imaging of the brain
revealed a sellar mass lesion homogeneously enhancedFigure 1 Transvaginal ultrasonograms. At initial surgery for ovarian cyst
enlarged ovary with multiple cysts at surgery (B).by gadolinium, with diameters of 18 × 11 × 10 mm,
which had compressed the optic chiasm upwards
(Figure 2A). She was transferred to our hospital and
transsphenoidal surgery achieved gross total tumor
removal (Figure 2B). Postoperative course was unevent-
ful, and serum concentrations of FSH, LH, and estradiol
were 8.81 mIU/ml, 3.10 mIU/ml, and 99 pg/ml, respec-
tively, all within the normal ranges. She was discharged
12 days after the surgery, and the ovarian cysts de-
creased in size without particular interventions, and did
not recur again.
Histological examination of the pituitary tumor dem-
onstrated basophilic cells with hyperchromatic nuclei
without atypism. These adenoma cells had acinar-like
arrangement (Figure 3A). Immunohistochemistry showed
positive reaction to anti-FSH-b antibody (1:200 dilution,
Leica, Wetzlar, Germany) and a-subunit (Roche, Basel,
Switzerland), but negative reaction to all other pitui-
tary hormones including LH-b (1:400 dilution, Leica)
(Figure 3B,C,D). The histological diagnosis was gonado-
troph cell adenoma. Additional examination of the former
ovarian cyst showed multiple large follicular cysts with
stratified follicular cell layer (Figure 4A,B). This region
showed positive immunohistochemical reaction to FSH-
receptor staining (1:800 dilution, Abcam, Cambridge, UK)
(Figure 4C).
Discussion
A few cases of FSH-secreting gonadotroph cell adenoma
manifesting as ovarian hyperstimulation have been
reported with the endocrinological characteristics, but the
true incidence of this condition including unnoticed or
subclinical cases remains unclear [1,7-11]. We retrospec-
tively reviewed patients who underwent surgical treatment
for gonadotroph cell adenoma at Kohnan Hospital bet-
ween April 2005 and March 2012. During this period, 200
patients were treated for gonadotroph cell adenoma
including 26 women under the age of 50 years. Two
(7.7%) of these 26 patients had a history of ovarian cysts, the ovaries contained enlarged multiple cysts (A). Photograph of the
Figure 2 Serial magnetic resonance images of the head. Pretreatment coronal images showing a sellar-suprasellar mass lesion (A, arrow).
Postoperative coronal images showing the tumor was grossly totally removed by a transsphenoidal approach (B).
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pressed LH level. Regretfully one patient’s follow-up data
was missed in out patient department.
Age is the most fundamental characteristic for the
diagnosis of this entity, because the response of the
ovary to FSH stimuli is important for the onset of ova-
rian hyperstimulation. In postmenopausal women, FSH
oversecretion cannot be recognized unless a very lowFigure 3 Photomicrographs of the pituitary adenoma. Hematoxylin-eo
(A, ×200). Immunostaining revealing intense and diffuse staining for follicle
(C, ×200), but no positive reaction to luteinizing hormone-b (D: ×200).LH level is noticed [12], so that all reported patients
with ovarian hyperstimulation are of reproductive age.
Although several FSH receptor mutations have been
identified for very rare cases of spontaneous ovarian
hyperstimulation [13,14], no pathological abnormalities
have been identified in the ovary in most cases of ovarian
hyperstimulation caused by FSH-secreting gonadotroph
cell adenoma. Therefore, regression of the ovariansin staining showing acinar-like arrangement of the adenoma cells
-stimulating hormone-b (B: ×200) and diffuse staining for a-subunit
Figure 4 Photomicrographs of the ovarian cysts. Hematoxylin-eosin staining showing multiple enlarged follicular cysts (A, ×40) and stratified
thick follicular cell layer (B, ×200). Immunostaining revealing intense staining of the follicular cells for follicle-stimulating hormone receptor
(C, ×200).
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appropriate FSH secretion in such cases.
Endocrinological pattern is also an important charac-
teristic in the diagnosis of this entity. Serum estradiol
level is elevated in response to FSH stimulation, which
is secreted in adenoma cells. Subsequently, the hypo-
thalamus-anterior pituitary gland axis is suppressed due
to the negative feedback mechanism. As a result, the
excessive FSH level is reduced to the normal range.
Serum LH level is also significantly reduced to below
the lower limit of the normal range, probably due to the
negative feedback mechanism or compression of the
normal pituitary gland by the tumor [4,5,7]. Apparent
normal FSH, suppressed LH, and high estradiol levels
can be considered as the characteristic endocrinological
profile of this FSH-secreting gonadotroph cell adenoma.
Serum prolactin concentration was elevated in most
cases, probably due to pituitary stalk compression by
the sellar tumor, the so-called stalk effect [15]. This
observation is considered to be a non-specific finding
with large pituitary adenomas.
Ovarian hyperstimulation syndrome is recognized as a
serious iatrogenic complication of fertility treatment
using human menopausal gonadotropin combined with
human chorionic gonadotropin [16,17] which also mani-
fests as enlarged multicystic ovaries [18]. However, thereare several differences between iatrogenic ovarian
hyperstimulation syndrome and ovarian hyperstimulation
caused by FSH-secreting gonadotroph cell adenoma. The
most significant clinical difference is the change of vascu-
lar permeability. Iatrogenic ovarian hyperstimulation syn-
drome is generally characterized by a systemic increase of
vascular permeability, manifesting as extravasation of fluid
into the peritoneal cavity or third space, which does not
occur in pituitary adenoma-induced ovarian hypersti-
mulation [6]. The correct diagnosis is difficult to establish
based only on the ovary symptoms without systemic
changes, because these patients are usually treated at the
gynecological clinic without referral to the neurosurgical
department. The present case had multiple ovarian cysts
but no ascites.
The clinical severity of ovarian hyperstimulation varies
greatly, because the biological activity of FSH is not always
uniform. Our Case 2 was diagnosed with ovarian cysts
and subsequently presented with visual disturbance. She
was treated by adenoma surgery for the purpose of optic
nerve decompression. However, retrospective review of
her preoperative endocrinological examination suggested
possible relationships with previous ovarian hypersti-
mulation, although several clinical data points were mis-
sing. Therefore, the gynecological history of patients with
sellar tumor of reproductive age requires careful evaluation.
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The present case of FSH-secreting gonadotroph cell
adenoma was the cause of recurrent ovarian cysts. We
emphasize the importance of pituitary imaging and de-
tailed endocrinological examinations as well as careful
evaluation of the gynecological history in women of
reproductive age to avoid unnecessary ovary surgery.
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